Use of factor XI inhibitors compared with DOACs in atrial fibrillation and thromboembolism prevention: a systematic review and meta-analysis of randomized-controlled trials
Event:
ESC Congress 2025
Topic:
Anticoagulants
Session:
Antithrombotic pharmacotherapy
